
    
      IC51-319 is a single-arm, open-label study that investigates immune responses in subjects
      undergoing revaccination after receiving the subpotent batch of IXIARO JEV09L37 during
      primary immunization.

      A total of up to 50 subjects having received primary immunization of IXIARO batch JEV09L37
      and who have not yet been revaccinated.
    
  